NCT03604198 2026-04-21
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
Phase 2 Active not recruiting
Corcept Therapeutics
Sparrow Pharmaceuticals
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Meyer Children's Hospital IRCCS
Mayo Clinic